Table 3.
General descriptors of funded RPGs by Health Condition Area and accounting for Hispanic/Latino ethnicity on the power of the planned sample size.
| Asthma | Cancer | Dementia | Diabetes | Liver Disease-GBD | Obesity | All | |
|---|---|---|---|---|---|---|---|
| Planned Hispanic/Latino Enrollment, Not Powered (Hispanic/Latino ethnicity not accounted in the power of the planned sample calculation) | |||||||
| N* | 25 | 172 | 18 | 61 | 17 | 99 | 365 |
| Planned Hispanic/Latino Sample Size | |||||||
| Primary data collection¶ (N) | 15 | 109 | 11 | 38 | 15 | 73 | 241 |
| Min | 7/9.1 | 1/0.5 | 9/9.8 | 2/1.3 | 7/7.8 | 3/0.8 | 1/0.5 |
| Max | 715/92.0 | 8,650/97.3 | 2,719/56.8 | 12,500/93.0 | 800/90.0 | 14,400/90.0 | 14,400/97.3 |
| Median | 143/41.8 | 34/15.0 | 50/34.4 | 50/23.6 | 201/40.0 | 100/37.5 | 72/26.3 |
| Secondary analyses only¶ (N) | 10 | 63 | 7 | 23 | 2 | 26 | 124 |
| Min | 10/13.1 | 2/0.6 | 74/0.8 | 21/2.5 | 700/5.2 | 11/1.2 | 2/0.6 |
| Max | 8,976/97.1 | 6,044,176/62.8 | 40,265/33.0 | 34,513/94.8 | 2,171/25.7 | 2,600/85.6 | 6,044,176/97.1 |
| Median | 2,835/59.2 | 388/13.2 | 2,319/8.9 | 2,072/20.1 | 1,436/15.4 | 1,602/23.6 | 934/16.9 |
| Age Group# | |||||||
| Infants (0–24 months) | 4 (16.0) | 35 (20.3) | 2 (11.1) | 4 (6.6) | 3 (17.6) | 4 (4.0) | 52 (14.2) |
| Children (0–17 years) | 8 (32.0) | 10 (5.8) | 1 (5.6) | 6 (9.8) | 3 (17.6) | 29 (29.3) | 50 (13.7) |
| Children (0–17 years) and Young adults (18–25 years) | 4 (16.0) | 2 (1.2) | 0 (0.0) | 2 (3.3) | 1 (5.9) | 4 (4.0) | 10 (2.7) |
| Adults (25–64 years) | 3 (12.0) | 94 (54.7) | 4 (22.2) | 32 (52.5) | 9 (52.9) | 30 (30.3) | 160 (43.8) |
| Adults, Older Adults (65+) | 0 (0.0) | 20 (11.6) | 11 (61.1) | 15 (24.6) | 1 (5.9) | 14 (14.1) | 56 (15.3) |
| Family study | 6 (24.0) | 11 (6.5) | 0 (0.0) | 1 (1.6) | 0 (0.0) | 18 (18.2) | 36 (9.9) |
| Not specified | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (1.6) | 0 (0.0) | 0 (0.0) | 1 (0.3) |
| Proposed Hispanic/Latino Enrollment, Powered (Hispanic/Latino ethnicity accounted in the power of the planned sample calculation) | |||||||
| N | 5 | 42 | 3 | 15 | 2 | 19 | 78 |
| Planned Hispanic/Latino Sample Size | |||||||
| Primary Data Collection¶ (N) | 2 | 20 | 3 | 5 | 1 | 10 | 39 |
| Min | 100/38.8 | 17/1.2 | 80/50.0 | 28/33.3 | 28/33.3 | 28/15.0 | 17/1.2 |
| Max | 155/66.7 | 47,438/96.3 | 366/83.3 | 1,000/50.0 | 28/33.3 | 2,312/94.9 | 47,438/96.3 |
| Median | 128/52.7 | 262/50.0 | 250/73.2 | 120/33.3 | 28/33.3 | 318/46.3 | 278/50.0 |
| Secondary Data Analyses Only¶ (N) | 3 | 22 | 0 | 10 | 1 | 9 | 39 |
| Min | 500/48.0 | 100/3.6 | NA | 748/10 | 47,438/22.0 | 748/10.0 | 100/3.6 |
| Max | 5,900/66.3 | 47,438/59.3 | NA | 334,298/66.7 | 47,438/22.0 | 47,438/64.1 | 334,298/66.7 |
| Median | 4,800/50.0 | 2,000/26.2 | NA | 36,166 (28.6) | 47,438/22.0 | 2,002/22.0 | 14,675/26.7 |
| Age Groups# | |||||||
| Infants (0–24 months) | 0 (0.0) | 2 (4.8) | 0 (0.0) | 2 (13.3) | 0 (0.0) | 2 (10.5) | 4 (5.1) |
| Children (0–17 years) | 3 (60.0) | 3 (7.1) | 0 (0.0) | 1 (6.7) | 0 (0.0) | 5 (26.3) | 11 (14.1) |
| Children (0–17 years) and Young adults (18–25 years) | 2 (40.0) | 3 (7.1) | 0 (0.0) | 1 (6.7) | 1 (50.0) | 1 (5.3) | 6 (7.7) |
| Adults (25–64 years) | 0 (0.0) | 20 (47.6) | 2 (66.7) | 8 (53.3) | 0 (0.0) | 2 (10.5) | 32 (41.0) |
| Adults, Older adults (65+) | 0 (0.0) | 11 (26.2) | 1 (33.3) | 1 (6.3) | 1 (50.0) | 4 (21.2) | 16 (20.5) |
| Family study | 0 (0.0) | 3 (7.1) | 0 (0.0) | 1 (6.7) | 0 (0.0) | 5 (26.3) | 8 (10.3) |
| Not specified | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (6.7) | 0 (0.0) | 0 (0.0) | 1 (1.3) |
| Focused (Planned sample was 100% Hispanic/Latino or studies focused on Hispanics/Latinos) | |||||||
| N* | 15 | 59 | 16 | 47 | 8 | 63 | 182 |
| Planned Hispanic/Latino Sample Size | |||||||
| Primary Data Collection¶ (N) | 14 | 46 | 12 | 34 | 6 | 52 | 143 |
| Min | 20/19.7 | 28/50.0 | 70/100.0 | 20/100.0 | 56/100.0 | 20/96.2 | 20/19.7 |
| Max | 4,000/100.0 | 6,000/100.0 | 6,539/100.0 | 2,200/100.0 | 500/100.0 | 4,014/100.0 | 6,539/100.0 |
| Median | 267/100.0 | 313/100.0 | 400/100.0 | 300/100.0 | 268/100.0 | 306/100.0 | 300/100.0 |
| Secondary Data Analyses Only¶ (N) | 1 | 13 | 4 | 13 | 2 | 11 | 39 |
| Min | 4,343/82.2 | 20/100.0 | 1,789/100.0 | 300/100.0 | 407/100.0 | 700/100.0 | 20/82.2 |
| Max | 4,343/82.2 | 6,800/100.0 | 8,809/100.0 | 5,638/100.0 | 2,539/100.0 | 230,000/100.0 | 230,000/100.0 |
| Median | 4,343/82.2 | 1,302/100.0 | 2,836/100.0 | 2,186/100.0 | 1,473/100.0 | 1,272/100.0 | 1,725/100.0 |
| Age Groups# | |||||||
| Infants (0–24 months) | 1 (6.7) | 6 (10.2) | 0 (0.0) | 4 (8.5) | 1 (12.5) | 3 (4.8) | 11 (6.0) |
| Children (0–17 years) | 7 (46.7) | 7 (11.9) | 0 (0.0) | 9 (19.1) | 2 (25.0) | 8 (12.7) | 31 (17.0) |
| Children (0–17 years) and Young adults (18–25 years) | 3 (20.0) | 0 (0.0) | 0 (0.0) | 2 (4.3) | 0 (0.0) | 5 (7.9) | 8 (4.4) |
| Adults (25–64 years) | 0 (0.0) | 32 (54.2) | 5 (31.3) | 26 (55.3) | 5 (62.5) | 32 (50.8) | 86 (47.3) |
| Adults, Older adults (65+) | 0 (0.0) | 12 (20.3) | 11 (68.8) | 5 (10.6) | 0 (0.0) | 7 (11.1) | 31 (17.0) |
| Family study | 4 (26.7) | 1 (1.7) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 8 (12.7) | 13 (7.1) |
| Not specified | 0 (0.0) | 1 (1.7) | 0 (0.0) | 1 (2.1) | 0 (0.0) | 0 (0.0) | 2 (1.1) |
Values under the “All” column represent the total and breakdown based on the 625 unique RPGs, and values under the disease category columns add up to 686 (392 Not-Powered, 86 Powered, and 208 Focused) since some studies were accounted in more than one RCDC disease category.
*
Results shown in numbers. The numbers presented by disease category and power of the sample add up to more than the total number in Table 1 because some studies were coded in more than one RCDC disease category.
#
Results shown in numbers, and percentage in parentheses.
¶
The proposed Hispanic/Latino sample size is shown as total number of Hispanic/Latino research participants and percentage from the total sample. The number and the percentage represent two separate distributions and do not coincide with each other.